gracecast-068_lung-cancer_sequist on acquired resistance to egfr
Published 13 years ago • 839 plays • Length 29:24Download video MP4
Download video MP3
Similar videos
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
14:43
gracecast-070_lung-cancer_q&a for acquired egfr tki and re-biopsying
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
26:27
novel egfr inhibitors in the setting of acquired resistance
-
5:34
gracecastuc-038_lung_managing acq. resistance to egfr therapy (and probably crizotinib, too)
-
3:07
third generation egfr tkis for acquired resistance
-
2:10
slcvl raez #17 treatment options for acquired resistance to egfr tkis: t790m-negative disease
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
10:16
overcoming resistance in egfr nsclc - lung cancer onctalk 2022
-
8:46
grace targeted therapies in lung cancer 2021 - liquid and tissue biopsies in acquired resistance
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md
-
3:46
q&a: how do oncologists approach compound egfr mutations? - targeted therapies in lung cancer 2023
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
3:43
how do you help your egfr patients make treatment decisions when their cancers grow?
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
5:30
targeted therapies forum, episode 2: the complimentary use of liquid and tissue biopsies
-
1:22
gracecastuc-066_lung_dr. lecia sequist on relevant emerging molecular targets in lung cancer
-
1:45
gracecastuc-034_lung_management strategies for acquired resistance to targeted therapies